| ZFIN ID: ZDB-EXP-141125-12 |
Experiment Conditions Description: chemical ablation: insulin secreting cell, chemical treatment: prednisolone, chemical treatment: metronidazole
| chemical ablation: insulin secreting cell |
|---|
| Name: | chemical ablation |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition which uses a chemical to ablate an anatomical structure or cell. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000169] |
| Name: | insulin secreting cell |
|---|---|
| Synonyms: | insulin secreting cells |
| Definition: | |
| Ontology: | Anatomy Ontology [ZFA:0009101] |
| chemical treatment: prednisolone |
|---|
| Name: | chemical treatment |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000111] |
| Name: | prednisolone |
|---|---|
| Synonyms: | (11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione, 1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione, 1,4-pregnadiene-3,20-dione-11beta,17alpha,21-triol, 11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione, 3,20-dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene, Delta(1)-dehydrocortisol, Delta(1)-dehydrohydrocortisone, Delta(1)-hydrocortisone, hydroretrocortine, metacortandralone, prednisolona, prednisolone, prednisolonum |
| Definition: | A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone. |
| Ontology: | ChEBI [CHEBI:8378] ( EBI ) |
| chemical treatment: metronidazole |
|---|
| Name: | chemical treatment |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000111] |
| Name: | metronidazole |
|---|---|
| Synonyms: | 1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole, 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole, 1-(beta-ethylol)-2-methyl-5-nitro-3-azapyrrole, 1-(beta-hydroxyethyl)-2-methyl-5-nitroimidazole, 1-(beta-oxyethyl)-2-methyl-5-nitroimidazole, 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol, 2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole, 2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole, 2-methyl-5-nitroimidazole-1-ethanol, metronidazol, metronidazole, metronidazolum |
| Definition: | A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. |
| Ontology: | ChEBI [CHEBI:6909] ( EBI ) |
| Publication: | Tsuji et al., 2014 |
|---|